GSK plc (GSK) Form 6-K — Jul 16, 2026

GSK plc disclosed transactions by Persons Discharging Managerial Responsibilities (PDMRs) and closely associated persons involving the acquisition of American Depositary Shares. These acquisitions were non-discretionary, resulting from the reinvestment of dividends paid to shareholders on July 9, 2026. The transactions occurred on the New York Stock Exchange between July 10 and July 14, 2026. A total of eleven individuals, including the President of the US and several independent directors, acquired shares at prices ranging from $51.6696 to $52.7353 per ADS.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.